{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T18:20:50Z","timestamp":1782757250736,"version":"3.54.5"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"15","funder":[{"DOI":"10.13039\/501100003196","name":"Ricerca Corrente","doi-asserted-by":"publisher","award":["WFR 2611892"],"award-info":[{"award-number":["WFR 2611892"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ricerca Corrente","doi-asserted-by":"publisher","award":["DDn. 1637\/13"],"award-info":[{"award-number":["DDn. 1637\/13"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"MIUR, Italian Ministry of Education, University and Research, \"hepatochip\"","doi-asserted-by":"publisher","award":["DD 207\/2018"],"award-info":[{"award-number":["DD 207\/2018"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Chronic infection with hepatitis C virus (HCV) is among the major\ncauses of hepatic fibrosis, cirrhosis, as well as hepatocellular carcinoma (HCC), and it\nis associated with a significant risk of developing lymphoproliferative disorders. The rate\nof clinical disease progression is variable depending on multiple host and viral factors, including\nimmune response.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>To perform a comprehensive epitope mapping of anti-HCV antibodies in patients\nsuffering from HCV-related liver or lymphoproliferative diseases, we analyzed clinical\nsamples on a peptide microarray platform made of 5952 overlapping 15-mer synthetic\npeptides derived from the whole HCV proteome. We evaluated the antibody profile of 71\nHCV-positive patients diagnosed with HCC, mixed cryoglobulinemia (MC), and HCV\nchronic infection. Antibody reactivity against virus peptides was detected in all HCVpositive\npatients. Importantly, the signal amplitude varied significantly within and between\ndiverse patient groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Antibody reactivity against C peptides were found generally low in HCV chronically\ninfected asymptomatic subjects and increasingly high in HCC and MC patients.\nMoreover, we found a statistically significant higher IgG response in HCC and MC patients\nagainst specific domains of HCV C, E2, NS3, NS4A, NS4B, NS5A, and p7 compared\nto HCV-positive subjects.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In conclusion, our data suggest that immune response against specific HCV\nprotein domains may represent useful biomarkers of disease progression among HCVpositive\npatients and suggest that peptide microarrays are good tools for the screening of\nimmunotherapy targets in preclinical HCV research.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867328666211104093718","type":"journal-article","created":{"date-parts":[[2021,11,5]],"date-time":"2021-11-05T07:13:41Z","timestamp":1636096421000},"page":"2736-2747","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Profiling the HCV Immune Response in Patients with Chronic Liver\nDiseases and Hepatocellular Carcinoma by Peptide Microarray\nAnalysis"],"prefix":"10.2174","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0972-5668","authenticated-orcid":true,"given":"Anna Lucia","family":"Tornesello","sequence":"first","affiliation":[{"name":"Department of Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS \\'Fondazione\nG. Pascale\\', 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Reimer","sequence":"additional","affiliation":[{"name":"JPT Peptide Technologies GmbH, Berlin,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlo","family":"Holenya","sequence":"additional","affiliation":[{"name":"JPT Peptide Technologies GmbH, Berlin,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Knaute","sequence":"additional","affiliation":[{"name":"JPT Peptide Technologies GmbH, Berlin ,Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pezzuto","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS \\'Fondazione\nG. Pascale\\', 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Izzo","sequence":"additional","affiliation":[{"name":"Hepatobiliary Surgery\nUnit, Istituto Nazionale Tumori IRCCS \\'Fondazione G. Pascale\\', 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Buonaguro","sequence":"additional","affiliation":[{"name":"Innovative Immunological\nModels, Istituto Nazionale Tumori IRCCS \\'Fondazione G. Pascale, 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Salomone","family":"Megna","sequence":"additional","affiliation":[{"name":"Infectious\nDiseases Unit, Azienda Ospedaliera San Pio, Benevento, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco Maria","family":"Buonaguro","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS \\'Fondazione\nG. Pascale\\', 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Tornesello","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology and Viral Oncology Unit, Istituto Nazionale Tumori IRCCS \\'Fondazione\nG. Pascale\\', 80131 Napoli, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"Gower E.","year":"2014","unstructured":"Gower E.; Estes C.; Blach S.; Razavi-Shearer K.; Razavi H.; Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014,61(1)(Suppl.),S45-S57","journal-title":"J Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"Mohd Hanafiah K.","year":"2013","unstructured":"Mohd Hanafiah K.; Groeger J.; Flaxman A.D.; Wiersma S.T.; Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013,57(4),1333-1342","journal-title":"Hepatology"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/liv.14324","volume":"40","author":"Razavi H.","year":"2020","unstructured":"Razavi H.; Sanchez Gonzalez Y.; Yuen C.; Cornberg M.; Global timing of hepatitis C virus elimination in high-income countries. Liver Int 2020,40(3),522-529","journal-title":"Liver Int"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1126\/science.aad1302","volume":"349","author":"Cox A.L.","year":"2015","unstructured":"Cox A.L.; MEDICINE. Global control of hepatitis C virus. Science 2015,349(6250),790-791","journal-title":"Science"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1056\/NEJMra1810477","volume":"380","author":"Thomas D.L.","year":"2019","unstructured":"Thomas D.L.; Global elimination of chronic hepatitis. N Engl J Med 2019,380(21),2041-2050","journal-title":"N Engl J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1306218","volume":"370","author":"Sulkowski M.S.","year":"2014","unstructured":"Sulkowski M.S.; Gardiner D.F.; Rodriguez-Torres M.; Reddy K.R.; Hassanein T.; Jacobson I.; Lawitz E.; Lok A.S.; Hinestrosa F.; Thuluvath P.J.; Schwartz H.; Nelson D.R.; Everson G.T.; Eley T.; Wind-Rotolo M.; Huang S.P.; Gao M.; Hernandez D.; McPhee F.; Sherman D.; Hindes R.; Symonds W.; Pasquinelli C.; Grasela D.M.; Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. N Engl J Med 2014,370(3),211-221","journal-title":"N Engl J Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.4254\/wjh.v9.i21.921","volume":"9","author":"Ahmed K.T.","year":"2017","unstructured":"Ahmed K.T.; Almashhrawi A.A.; Ibdah J.A.; Tahan V.; Is the 25-year hepatitis C marathon coming to an end to declare victory? World J Hepatol 2017,9(21),921-929","journal-title":"World J Hepatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2174\/1872213X08666140704115149","volume":"8","author":"Garcia A.","year":"2014","unstructured":"Garcia A.; Fernandez S.; Toro F.; De Sanctis J.B.; An overview of hepatitis C vaccines. Recent Pat Inflamm Allergy Drug Discov 2014,8(2),85-91","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"ref=9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a037093","volume":"10","author":"Tabata K.","year":"2020","unstructured":"Tabata K.; Neufeldt C.J.; Bartenschlager R.; Hepatitis C.; Virus replication. Cold Spring Harb Perspect Med 2020,10(3)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.virusres.2015.12.003","volume":"218","author":"Saik O.V.","year":"2016","unstructured":"Saik O.V.; Ivanisenko T.V.; Demenkov P.S.; Ivanisenko V.A.; Interactome of the hepatitis C virus: Literature mining with ANDSys-tem. Virus Res 2016,218,40-48","journal-title":"Virus Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/v2092108","volume":"2","author":"Banerjee A.","year":"2010","unstructured":"Banerjee A.; Ray R.B.; Ray R.; Oncogenic potential of hepatitis C virus proteins. Viruses 2010,2(9),2108-2133","journal-title":"Viruses"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","volume":"285","author":"Harris H.J.","year":"2010","unstructured":"Harris H.J.; Davis C.; Mullins J.G.; Hu K.; Goodall M.; Farquhar M.J.; Mee C.J.; McCaffrey K.; Young S.; Drummer H.; Balfe P.; McKeating J.A.; Claudin association with CD81 defines hepatitis C virus entry. J Biol Chem 2010,285(27),21092-21102","journal-title":"J Biol Chem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1002\/hep.20239","volume":"39","author":"Major M.E.","year":"2004","unstructured":"Major M.E.; Dahari H.; Mihalik K.; Puig M.; Rice C.M.; Neumann A.U.; Feinstone S.M.; Hepatitis C virus kinetics and host re-sponses associated with disease and outcome of infection in chimpanzees. Hepatology 2004,39(6),1709-1720","journal-title":"Hepatology"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/hep.26770","volume":"59","author":"Wieland S.","year":"2014","unstructured":"Wieland S.; Makowska Z.; Campana B.; Calabrese D.; Dill M.T.; Chung J.; Chisari F.V.; Heim M.H.; Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver. Hepatology 2014,59(6),2121-2130","journal-title":"Hepatology"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/j.gastro.2009.07.050","volume":"137","author":"Liang Y.","year":"2009","unstructured":"Liang Y.; Shilagard T.; Xiao S.Y.; Snyder N.; Lau D.; Cicalese L.; Weiss H.; Vargas G.; Lemon S.M.; Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 2009,137(4),1448-1458","journal-title":"Gastroenterology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1086\/432478","volume":"41","author":"Netski D.M.","year":"2005","unstructured":"Netski D.M.; Mosbruger T.; Depla E.; Maertens G.; Ray S.C.; Hamilton R.G.; Roundtree S.; Thomas D.L.; McKeating J.; Cox A.; Humoral immune response in acute hepatitis C virus infection. Clin Infect Dis 2005,41(5),667-675","journal-title":"Clin Infect Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.3851\/IMP2222","volume":"17","author":"Dustin L.B.","year":"2012","unstructured":"Dustin L.B.; Charles E.D.; Primary, post-primary and non-specific immunoglobulin M responses in HCV infection. Antivir Ther 2012,17(7 Pt B),1449-1452","journal-title":"Antivir Ther"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","volume":"61","author":"Westbrook R.H.","year":"2014","unstructured":"Westbrook R.H.; Dusheiko G.; Natural history of hepatitis C. J Hepatol 2014,61(1)(Suppl.),S58-S68","journal-title":"J Hepatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2049936115585942","volume":"3","author":"Cacoub P.","year":"2016","unstructured":"Cacoub P.; Comarmond C.; Domont F.; Savey L.; Desbois A.C.; Saadoun D.; Extrahepatic manifestations of chronic hepatitis C virus infection. Ther Adv Infect Dis 2016,3(1),3-14","journal-title":"Ther Adv Infect Dis"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-018-0009-4","volume":"4","author":"Roccatello D.","year":"2018","unstructured":"Roccatello D.; Saadoun D.; Ramos-Casals M.; Tzioufas A.G.; Fervenza F.C.; Cacoub P.; Zignego A.L.; Ferri C.; Cryoglobulinae-mia. Nat Rev Dis Primers 2018,4(1),11","journal-title":"Nat Rev Dis Primers"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2019.11.011","volume":"72","author":"Brasher N.A.","year":"2020","unstructured":"Brasher N.A.; Eltahla A.A.; Underwood A.; Boo I.; Rizzetto S.; Walker M.R.; Rodrigo C.; Luciani F.; Maher L.; Drummer H.E.; Tedla N.; Lloyd A.R.; Bull R.A.; B cell immunodominance in primary hepatitis C virus infection. J Hepatol 2020,72(4),670-679","journal-title":"J Hepatol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1002\/1097-0142(195405)7:3<462:AID-CNCR2820070308>3.0.CO;2-E","volume":"7","author":"Edmondson H.A.","year":"1954","unstructured":"Edmondson H.A.; Steiner P.E.; Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954,7(3),462-503","journal-title":"Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jim.2014.11.006","volume":"416","author":"Stephenson K.E.","year":"2015","unstructured":"Stephenson K.E.; Neubauer G.H.; Reimer U.; Pawlowski N.; Knaute T.; Zerweck J.; Korber B.T.; Barouch D.H.; Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine development. J Immunol Methods 2015,416,105-123","journal-title":"J Immunol Methods"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-1759(02)00137-0","volume":"267","author":"Frank R.","year":"2002","unstructured":"Frank R.; The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. J Immunol Methods 2002,267(1),13-26","journal-title":"J Immunol Methods"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"54253","DOI":"10.18632\/oncotarget.9801","volume":"7","author":"Pezzuto F.","year":"2016","unstructured":"Pezzuto F.; Izzo F.; Buonaguro L.; Annunziata C.; Tatangelo F.; Botti G.; Buonaguro F.M.; Tornesello M.L.; Tumor specific muta-tions in TERT promoter and CTNNB1 gene in hepatitis B and hepatitis C related hepatocellular carcinoma. Oncotarget 2016,7(34),54253-54262","journal-title":"Oncotarget"},{"key":"ref=26","first-page":"13","volume":"15","author":"Pezzuto F.I.F.","year":"2021","unstructured":"Pezzuto F.I.F.; De Luca P.; Biffali E.; Buonaguro L.; Tatangelo F.; Buonaguro F.M.; Tornesello M.L.; Clinical significance of te-lomerase reverse-transcriptase promoter mutations in hepatocellular carcinoma. Cancers (Basel) 2021,15(13),13","journal-title":"Cancers (Basel)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1073\/pnas.0902749106","volume":"106","author":"Zhang P.","year":"2009","unstructured":"Zhang P.; Zhong L.; Struble E.B.; Watanabe H.; Kachko A.; Mihalik K.; Virata M.L.; Alter H.J.; Feinstone S.; Major M.; Deple-tion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activi-ty. Proc Natl Acad Sci USA 2009,106(18),7537-7541","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1128\/JVI.01941-12","volume":"87","author":"Keck Z.","year":"2013","unstructured":"Keck Z.; Wang W.; Wang Y.; Lau P.; Carlsen T.H.; Prentoe J.; Xia J.; Patel A.H.; Bukh J.; Foung S.K.; Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycopro-tein. J Virol 2013,87(1),37-51","journal-title":"J Virol"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002895","volume":"8","author":"Morin T.J.","year":"2012","unstructured":"Morin T.J.; Broering T.J.; Leav B.A.; Blair B.M.; Rowley K.J.; Boucher E.N.; Wang Y.; Cheslock P.S.; Knauber M.; Olsen D.B.; Ludmerer S.W.; Szabo G.; Finberg R.W.; Purcell R.H.; Lanford R.E.; Ambrosino D.M.; Molrine D.C.; Babcock G.J.; Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzees. PLoS Pathog 2012,8(8)","journal-title":"PLoS Pathog"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v4010001","volume":"4","author":"Tarr A.W.","year":"2012","unstructured":"Tarr A.W.; Urbanowicz R.A.; Ball J.K.; The role of humoral innate immunity in hepatitis C virus infection. Viruses 2012,4(1),1-27","journal-title":"Viruses"},{"key":"ref=31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062684","volume":"8","author":"Deng Y.","year":"2013","unstructured":"Deng Y.; Guan J.; Wen B.; Zhu N.; Chen H.; Song J.; Yang Y.; Wang Y.; Tan W.; Induction of broadly neutralising HCV anti-bodies in mice by integration-deficient lentiviral vector-based pseudotyped particles. PLoS One 2013,8(4)","journal-title":"PLoS One"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0140-6736(94)92054-0","volume":"343","author":"Courouce A.M.","year":"1994","unstructured":"Courouce A.M.; Bouchardeau F.; Girault A.; Le Marrec N.; Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994,343(8901),853-854","journal-title":"Lancet"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1155\/2007\/796325","volume":"21","author":"Grebely J.","year":"2007","unstructured":"Grebely J.; Raffa J.D.; Lai C.; Krajden M.; Conway B.; Tyndall M.W.; Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can J Gastroenterol 2007,21(7),447-451","journal-title":"Can J Gastroenterol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1128\/jcm.31.6.1586-1591.1993","volume":"31","author":"Ferroni P.","year":"1993","unstructured":"Ferroni P.; Mascolo G.; Zaninetti M.; Colzani D.; Pregliasco F.; Pirisi M.; Barbone F.; Gasparini V.; Identification of four epitopes in hepatitis C virus core protein. J Clin Microbiol 1993,31(6),1586-1591","journal-title":"J Clin Microbiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0009-8981(02)00245-0","volume":"325","author":"El Awady M.K.","year":"2002","unstructured":"El Awady M.K.; El-Demellawy M.A.; Khalil S.B.; Galal D.; Goueli S.A.; Synthetic peptide-based immunoassay as a supplemental test for HCV infection. Clin Chim Acta 2002,325(1-2),39-46","journal-title":"Clin Chim Acta"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2249.1993.tb05929.x","volume":"91","author":"S&#xE4;llberg M.","year":"1993","unstructured":"S&#xE4;llberg M.; Rud&#xE9;n U.; Wahren B.; Magnius L.O.; Antigenic regions within the hepatitis C virus envelope 1 and non-structural pro-teins: identification of an IgG3-restricted recognition site with the envelope 1 protein. Clin Exp Immunol 1993,91(3),489-494","journal-title":"Clin Exp Immunol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/jcm.30.8.1989-1994.1992","volume":"30","author":"S&#xE4;llberg M.","year":"1992","unstructured":"S&#xE4;llberg M.; Rud&#xE9;n U.; Wahren B.; Magnius L.O.; Immunodominant regions within the hepatitis C virus core and putative matrix proteins. J Clin Microbiol 1992,30(8),1989-1994","journal-title":"J Clin Microbiol"},{"key":"ref=38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006735","volume":"13","author":"Gopal R.","year":"2017","unstructured":"Gopal R.; Jackson K.; Tzarum N.; Kong L.; Ettenger A.; Guest J.; Pfaff J.M.; Barnes T.; Honda A.; Giang E.; Davidson E.; Wil-son I.A.; Doranz B.J.; Law M.; Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput muta-genesis. PLoS Pathog 2017,13(12)","journal-title":"PLoS Pathog"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.virol.2014.04.018","volume":"462-463","author":"Atoom A.M.","year":"2014","unstructured":"Atoom A.M.; Taylor N.G.; Russell R.S.; The elusive function of the hepatitis C virus p7 protein. Virology 2014,462-463,377-387","journal-title":"Virology"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"11646","DOI":"10.1073\/pnas.1834545100","volume":"100","author":"Sakai A.","year":"2003","unstructured":"Sakai A.; Claire M.S.; Faulk K.; Govindarajan S.; Emerson S.U.; Purcell R.H.; Bukh J.; The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci USA 2003,100(20),11646-11651","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2020.05.038","volume":"182","author":"Liu J.","year":"2020","unstructured":"Liu J.; Tang W.; Budhu A.; Forgues M.; Hernandez M.O.; Candia J.; Kim Y.; Bowman E.D.; Ambs S.; Zhao Y.; Tran B.; Wu X.; Koh C.; Surana P.; Liang T.J.; Guarnera M.; Mann D.; Rajaure M.; Greten T.F.; Wang Z.; Yu H.; Wang X.W.; A viral expo-sure signature defines early onset of hepatocellular carcinoma. Cell 2020,182(2),317-328","journal-title":"Cell"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"aaa0698","DOI":"10.1126\/science.aaa0698","volume":"348","year":"2015","unstructured":"Xu, G.J.; Kula, T.; Xu, Q.; Li, M.Z.; Vernon, S.D.;\nNdung\u2019u, T.; Ruxrungtham, K.; Sanchez, J.; Brander, C.;\nChung, R.T.; O\u2019Connor, K.C.; Walker, B.; Larman, H.B.;\nElledge, S.J. Viral immunology. Comprehensive serological\nprofiling of human populations using a synthetic human virome. Science 2015,348(6239),aaa0698","journal-title":"Science"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211104093718","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197668\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867328666211104093718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T05:25:39Z","timestamp":1657171539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197668\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":42,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867328666211104093718","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-04-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}